Treatment of rheumatoid arthritis (RA) may differ among rheumatologists and currently, clear
and consensual international recommendations on RA treatment are not available. In this …

The American College of Rheumatology (ACR) most recently published recommendations
for the use of diseasemodifying antirheumatic drugs (DMARDs) and biologic agents in the …

Nontuberculous mycobacteria (NTM) represent over 190 species and subspecies, some of
which can produce disease in humans of all ages and can affect both pulmonary and …

A significant knowledge gap exists concerning the geographical distribution of nontuberculous
mycobacteria (NTM) isolation worldwide. To provide a snapshot of NTM species …

Tofacitinib is the first Janus kinase (JAK) inhibitor commercially approved for the treatment
of rheumatoid arthritis. This compound and a number of other JAK inhibitors are currently …

Non-tuberculous mycobacteria (NTM) are ubiquitous environmental organisms that can cause
chronic pulmonary infection, particularly in individuals with pre-existing inflammatory lung …

Background . Nontuberculous mycobacteria (NTM) are important human pathogens, yet little
is known about disease prevalence in the United States. Reports suggest prevalence has …

… Correspondence and requests for reprints should be addressed to Kevin L. Winthrop, MD,
MPH, CEI/OHSU, 3375 SW Terwilliger Blvd., Portland, OR 97239. E-mail: [email protected] …

Objectives To provide an update of the EULAR rheumatoid arthritis (RA) management
recommendations addressing the most recent developments in the field. Methods An international …

Because of their potent anti-inflammatory properties, corticosteroids have been used for
decades to treat many diseases, including rheumatic diseases. They are frequently used in …